News

Amgen claims that Vectibix, in conjuction with chemotherapy, offers an an important treatment option for patients with wild-type KRAS mCRC. Accoding to the company, the results from the

BioClinica said the new EDA will collect planning information from all of Millennium’s Optimizer-simulated protocols in a central repository and provide an enterprise-wide view of the demand over

The company has posted net income of $13.1m, an increase of 42%, as compared to the net income of $9.2m for the year ago period. Gross profit was

Oracle Health Sciences Enterprise Healthcare Analytics suite and Oracle Healthcare Master Person Index – along with Oracle Fusion Middleware components and Oracle Database 11g have been selected by

Hamamatsu Photonics claims that its new product provides high resolution, high sensitivity and high speed imaging for advanced applications. The camera contains back-thinned EMCCD with Peak Quantum Efficiency

Nile intends to develop Cenderitide as an outpatient therapy to be delivered to acutely decompensated heart failure (ADHF) patients continuously for up to 90 days after discharge from

The OX51 project aims to develop a sublingual dosage form for the treatment of acute intensive pain episodes in relation to care-related diagnostic or therapeutic procedures for patients

The NBER researchers are expected to use the data from Medidata’s proprietary clinical trial cost databases PICAS and CROCAS, accessed through Medidata Grants Manager and Medidata CRO Contractor,

The licensed technology relates to the discoveries that miR-33a and miR-33b down-regulate target genes involved in cholesterol transport and genes related to metabolic syndrome. Additionally, Regulus also controls